
Petco Health & Wellness Company, Inc.
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Total net sales | $1.03B+2.6% | $999.6M+1.8% | $981.6M+21.9% | $805.5M-86.1% | $5.81B |
| Total cost of sales | $627.5M+1.4% | $618.8M-2.1% | $631.8M+10.1% | $573.6M-83.0% | $3.38B |
| Gross profit | $2.31B-0.8% | $2.32B-1.3% | $2.35B-3.0% | $2.43B+0.0% | $2.43B |
| Selling, general and administrative expenses | $2.18B-5.7% | $2.32B+0.2% | $2.31B+5.0% | $2.20B+1.9% | $2.16B |
| Goodwill impairment | $0-100.0% | $1.22B | — | — | $0 |
| Operating income (loss) | $120.4M+1608.0% | $7.1M+100.6% | -$1.18B-623.3% | $225.6M-15.2% | $266.1M |
| Interest income | -$6.3M-69.8% | -$3.7M-9.1% | -$3.4M-229.9% | -$1.0M-1564.5% | -$62K |
| Interest expense | $131.2M-8.6% | $143.5M-4.9% | $150.9M+48.5% | $101.6M+31.3% | $77.4M |
| Loss on partial extinguishment of debt | $565K-38.6% | $920K | — | — | — |
| Other non-operating income | $0+100.0% | -$4.8M-1.5% | -$4.7M-137.3% | $12.7M+136.7% | -$34.5M |
| Loss before income taxes and income from equity method investees | -$5.0M+96.1% | -$128.0M+90.3% | -$1.32B-1279.2% | $112.3M-44.5% | $202.4M |
| Income tax expense (benefit) | $6.3M+183.8% | -$7.5M+72.9% | -$27.6M-178.1% | $35.3M-33.9% | $53.5M |
| Income from equity method investees | -$20.4M-9.0% | -$18.7M-15.3% | -$16.2M-24.8% | -$13.0M-19.2% | -$10.9M |
| Consolidated net income (loss) | $9.1M+108.9% | -$101.8M+92.0% | -$1.28B-1523.9% | $89.9M-43.7% | $159.8M |
| Net income (loss) attributable to Class A and B-1 common stockholders | $9.1M+108.9% | -$101.8M+92.0% | -$1.28B-1509.9% | $90.8M-44.8% | $164.4M |
| Basic | $279.6M+2.2% | $273.4M+2.2% | $267.5M+0.8% | $265.5M+0.5% | $264.3M |
| Diluted | $286.1M+4.7% | $273.4M+2.2% | $267.5M+0.6% | $266.0M+0.2% | $265.3M |
| Products | |||||
| Services and other | |||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Petco returned to positive comparable sales growth in Q1 2026 with $1.5B revenue and exceeded profitability outlook, reaffirming full-year guidance
“Our strong first-quarter results provide clear, early validation that our Phase 3 'Reach for the Sky' strategy is working.”
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-13 | 2026-03-17 | Venezia Patrick J | Chief Revenue Officer | Sale | 102.0K | $3.42 | $349K | 398.8K | View |
Informational purposes only, not investment advice.